Physician profile
Newsha Lajevardi
NPI 1225392095
$2,827.68
in general payments reported to CMS, 2019-2025
20 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $413 · 2021: $271 · 2022: $682 · 2023: $476 · 2024: $100 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.75 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $995.31 | 2021-2025 | |
| Almirall LLC | $400.00 | 2020 | |
| Galderma Laboratories, L.P. | $387.41 | 2019-2022 | |
| Allergan, INC. | $271.66 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $101.00 | 2019-2025 | Cabtreo |
| Eli Lilly and Company | $99.00 | 2025 | |
| Genzyme Corporation | $76.64 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $73.13 | 2021-2023 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $72.70 | 2023 | Sotyktu |
| Pfizer INC. | $65.57 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $61.97 | 2021-2023 | |
| Organon LLC | $51.20 | 2025 | |
| Biofrontera INC. | $39.74 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Solta Medical, A Division of Bausch Health US, LLC | $25.39 | 2025 | Clear+Brilliant |
| Helsinn Therapeutics (U.S.), INC. | $21.73 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $19.59 | 2022 | |
| Mayne Pharma Commercial LLC | $18.49 | 2022 | |
| Smith+Nephew, INC. | $17.04 | 2023 | Collagenase Santyl |
| Sebela Pharmaceuticals INC. | $15.65 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Newsha Lajevardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.